Literature DB >> 16977796

Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas.

Marek Pawlikowski1.   

Abstract

Male rat pituitary glands, diethylstilbestrol (DES)-induced rat pituitary tumors and 12 human pituitary adenomas were immunostained with antibodies raised against AT1 and AT2 angiotensin receptor proteins. Positive immunostaining of AT1 was observed in a subpopulation of anterior and intermediate pituitary lobe cells as well as in some nerve endings of the neurohypophysis. In the DES-induced rat pituiary tumors, the subpopulation of AT1-immunnopositive cells was smaller than in the non-tumoral anterior pituitary. In human pituitary adenomas, weak AT1 immunostaining was found in 5 tumors. In the remaining adenomas, the AT1 immunostaining was trace (doubtful) or absent. The AT1 immunostaining in the peritumoral non-neoplastic pituitary tissue was stronger than that observed in the tumors. The normal rat pituitaries and rat tumors did not show immunostaining with anti-AT2 antibody. In human pituitary adenomas, the tumoral cells were AT2- negative but moderate to strong AT2 immunostaining was observed in intratumoral blood vessel walls. The data suggest that the experimental (in rat) and spontaneous (in man) pituitary tumorigenesis is associated with the down-regulation of AT1 receptors. The expression of AT2 receptors, in turn, may be connected with the process of tumoral neo-angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16977796

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  7 in total

1.  The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.

Authors:  Dorota Ptasinska-Wnuk; Slawomir A Mucha; Hanna Lawnicka; Jolanta Fryczak; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

2.  The involvement of angiotensin type 1 and type 2 receptors in estrogen-induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary.

Authors:  Hanna Lawnicka; Dorota Ptasinska-Wnuk; Slawomir Mucha; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  ScientificWorldJournal       Date:  2012-04-26

3.  Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways.

Authors:  Dorota Ptasinska-Wnuk; Hanna Lawnicka; Slawomir Mucha; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  ScientificWorldJournal       Date:  2012-04-24

4.  Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases.

Authors:  Eleanor I Ager; Way W Chong; Shu-Wen Wen; Christopher Christophi
Journal:  Cancer Cell Int       Date:  2010-06-28       Impact factor: 5.722

5.  Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.

Authors:  Eleanor I Ager; Shu Wen Wen; Joyna Chan; Way W Chong; Jaclyn H Neo; Christopher Christophi
Journal:  BMC Cancer       Date:  2011-06-26       Impact factor: 4.430

6.  Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy.

Authors:  Long-Hai Feng; Hui-Chuan Sun; Xiao-Dong Zhu; Shi-Zhe Zhang; Kang-Shuai Li; Xiao-Long Li; Yan Li; Zhao-You Tang
Journal:  Ann Transl Med       Date:  2019-12

7.  Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary.

Authors:  Courtney Premer; Courtney Lamondin; Ann Mitzey; Robert C Speth; Mark S Brownfield
Journal:  Int J Hypertens       Date:  2013-03-19       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.